Skip to main content
OpenTrials
Completed

NCT Number: NCT04704193

Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes

An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Genetic Testing

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (18 years of age or older)
  • Diagnosed with malignant ovarian tumor or malignant pancreatic adenocarcinoma

Exclusion criteria

  • Children (<18 years of age)
  • Unable to complete surveys
  • Previous germline genetic testing

Treatment and study plan

Survey of Decision Aid

Other

The decision aid will be evaluated by a survey administered to those who have used the tool.

Primary outcomes

  1. Participant Satisfaction With How Educational Information is Presented in the Decision Aid

    Time frame: This outcome will be measured immediately following completion of the decision aid. The average completion time of the decision aid is 14 minutes.

    Measured with 6 items on a questionnaire that asks participants to rate the way certain information is presented on the decision aid. Each item is rated on a scale of 1 to 4, with 1 being poor and 4 being excellent.

Secondary outcomes

  1. Total Time Spent on Decision Aid

    Time frame: From the start of the decision aid to the completion of the decision aid

    The total amount of minutes spent on the decision aid

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Collaborators

  • Boston Medical Center
  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Jan 11, 2021
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.